Watchdog: '$99 gummies can change how cells age' — read the claim against the trial record

NAD+ is a genuinely important molecule: mitochondria need it to make energy, and levels fall with age. That true sentence is now doing heavy lifting in supplement marketing. A New York Post shopping piece published October 16, 2026 headlines a $99 NAD+ gummy product with a study claim that it 'can change how cells age,' paired with skin that 'looks at least ten years younger.'

Here is the gap readers should see. Nicotinamide riboside products have been shown to raise NAD+ levels in blood within weeks. Raising a biomarker is not the same as changing how cells age in any way a person can feel or a trial can measure — and the strongest recent test of that distinction was not kind to the marketing version.

What did the biggest recent NAD+ trial find?

The year-long NOPARK randomized trial — 410 people with early Parkinson's disease at 11 Norwegian centers, published in JAMA and reported October 8, 2026 — found no clinical benefit from nicotinamide riboside. Symptoms worsened slightly more on NR than on placebo (a modest, below-clinical-importance difference), brain imaging showed no slowing of dopamine-system changes, even though NR clearly increased NAD metabolism. The study director's conclusion was plain: increased NAD did not translate into clinical improvement.

How should you read NAD+ product claims?

Ask three questions. Did the study measure NAD+ in blood, or an outcome that matters — strength, cognition, skin, disease course? Was it in people, randomized, and long enough? And does the headline quote the study, or a shopper's impression? NAD+ biology deserves serious research; gummy marketing deserves the watchdog label until human outcome data — not biomarker data — supports it. This is also why intravenous NAD+ claims face the same test: a 2026 systematic review found no eligible clinical trials supporting IV NAD+ for anti-aging or wellness use.

Where the evidence stands

• Established: Oral NAD+ precursors reliably raise blood NAD+ metabolites in humans; NAD+ is essential to mitochondrial energy production.
• Contested: Marketing claims that NAD+ gummies change cellular aging or make skin look a decade younger — based on biomarker changes and impressions, not randomized human outcome trials.
• Absent: Randomized human evidence that NAD+ supplements or IV NAD+ improve skin age, slow aging, or — per the 410-person NOPARK trial in JAMA — slow Parkinson's progression.